Indian Pharmaceutical Market
-
{
- All
- News
-
Trump's 100% Tariff On Pharma Will Not Impact Generic Makers: Industry Leaders
- Friday September 26, 2025
- India News | Press Trust of India
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
-
www.ndtv.com
-
Volume Decline Muted Pharmaceutical Market Growth In November
- Tuesday December 22, 2020
- Edited by: Nikita Prasad
The pharmaceutical market reported 128.3 billion total sales in November 2020 and decline in volume can be attributed to the lower sales of the acute therapy products
-
www.ndtvprofit.com
-
India's Pharma Sector Posts 12% Growth in February: Report
- Sunday March 13, 2016
- Press Trust of India
Domestic pharmaceutical market grew at 12 per cent year-on-year in February, broadly in line with the average of 12.9 per cent since April 2015, primarily due to steady volumes, sustained healthy price hikes and new launches, a report said.
-
www.ndtvprofit.com
-
Trump's 100% Tariff On Pharma Will Not Impact Generic Makers: Industry Leaders
- Friday September 26, 2025
- India News | Press Trust of India
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
-
www.ndtv.com
-
Volume Decline Muted Pharmaceutical Market Growth In November
- Tuesday December 22, 2020
- Edited by: Nikita Prasad
The pharmaceutical market reported 128.3 billion total sales in November 2020 and decline in volume can be attributed to the lower sales of the acute therapy products
-
www.ndtvprofit.com
-
India's Pharma Sector Posts 12% Growth in February: Report
- Sunday March 13, 2016
- Press Trust of India
Domestic pharmaceutical market grew at 12 per cent year-on-year in February, broadly in line with the average of 12.9 per cent since April 2015, primarily due to steady volumes, sustained healthy price hikes and new launches, a report said.
-
www.ndtvprofit.com